Home > Perspectives on drugs: comorbidity of substance use and mental health disorders in Europe.

(2016) Perspectives on drugs: comorbidity of substance use and mental health disorders in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

[img]
Preview
PDF (Perspectives on drugs: comorbidity of substance use) - Published Version
475kB

URL: http://emcdda.europa.eu/topics/pods/comorbidity-su...


Comorbidity of substance use and mental health disorders refers to the co-occurrence of a substance use disorder and another mental health disorder in the same individual. In Europe, the presence of psychiatric disorders associated with substance use disorders has become an important issue in drug policy and treatment provision. This is a result of the high prevalence of comorbidity, the complexity of treating it, and its association with poor treatment outcomes for those affected. This analysis explains what comorbidity is, its implications for care, types of service provision available in Europe and considers key issues for the future.

Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Alcohol or other drugs in general
Intervention Type:AOD disorder treatment method, AOD disorder harm reduction
Date:May 2016
Pages:9 p.
Publisher:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Lisbon
EndNote:View
Subjects:A Substance use, abuse, and dependence > Prevalence > Problem substance use
G Health and disease > State of health > Mental health
G Health and disease > Substance related disorder > Dual diagnosis (comorbidity)
VA Geographic area > Europe

Repository Staff Only: item control page